A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT ID: NCT05288166
Last Updated: 2025-06-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
925 participants
INTERVENTIONAL
2022-04-14
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
NCT03706365
Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
NCT04408924
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer
NCT04298983
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
NCT05113537
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
NCT05999968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abemaciclib
Participants received 200 milligram (mg) abemaciclib twice daily (BID) in combination with standard doses of 1000 mg abiraterone acetate once daily and 5mg prednisone BID administered orally on a continuous dosing schedule on days 1 through 28 of a 28-day cycle until radiographic and/or symptomatic progression or until another discontinuation criterion is met.
Abemaciclib
Administered orally.
Abiraterone
Administered orally.
Prednisone or Prednisolone
Administered orally.
Placebo
Participants received placebo BID in combination with standard doses of 1000 mg abiraterone acetate once daily and 5mg prednisone BID administered orally on a continuous dosing schedule on days 1 through 28 of a 28-day cycle until radiographic and/or symptomatic progression or until another discontinuation criterion is met.
Abiraterone
Administered orally.
Prednisone or Prednisolone
Administered orally.
Placebo for Abemaciclib
Administered orally.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abemaciclib
Administered orally.
Abiraterone
Administered orally.
Prednisone or Prednisolone
Administered orally.
Placebo for Abemaciclib
Administered orally.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High-risk metastatic hormone-sensitive prostate cancer. High risk is defined as:
* Greater than or equal to (≥)4 bone metastases by bone scan and/or
* ≥1 visceral metastases by computed tomography or magnetic resonance imaging
* Must have initiated androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonist/antagonist or bilateral orchiectomy prior to randomization. Up to 3 months of ADT prior to randomization is permitted with or without first-generation anti-androgen.
* Adequate organ function
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Exclusion Criteria
* Development of metastatic prostate cancer in the context of castrate levels of testosterone
* Received any prior systemic therapy for metastatic prostate cancer (including investigational agents), except for ADT and first-generation anti-androgen
* Clinically significant cardiovascular disease as evidenced by myocardial infarction, arterial thrombotic events, or severe/unstable angina in the past 6 months, or New York Heart Association Class II to IV heart failure
* History of syncope of cardiovascular etiology, ventricular arrhythmia of pathological origin, or sudden cardiac arrest. Chronic and hemodynamically stable atrial arrhythmia well-controlled on medical therapy is permitted
* Uncontrolled hypertension
* Clinically active or chronic liver disease, moderate/severe hepatic impairment
* Known untreated central nervous system (CNS) metastasis. Participants with a history of treated brain metastases are eligible if stable for at least 8 weeks prior to randomization and off corticosteroid for at least 2 weeks prior to randomization
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Role: STUDY_DIRECTOR
Eli Lilly and Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Oncology Associates, P.C. - HOPE
Prescott, Arizona, United States
Arizona Oncology Associates, P.C. - HOPE
Prescott Valley, Arizona, United States
The University of Arizona Cancer Center - North Campus
Tucson, Arizona, United States
Genesis Cancer and Blood Institute
Hot Springs, Arkansas, United States
St. Bernards Medical Center
Jonesboro, Arkansas, United States
Highlands Oncology Group
Springdale, Arkansas, United States
Orange Coast Memorial Medical Center
Fountain Valley, California, United States
Providence Medical Foundation
Fullerton, California, United States
Moores Cancer Center
La Jolla, California, United States
MemorialCare Health System - Long Beach Medical Center
Long Beach, California, United States
Cancer and Blood Specialty Clinic
Los Alamitos, California, United States
UCLA Hematology/Oncology - Santa Monica
Los Angeles, California, United States
Torrance Memorial Physician Network / Cancer Care
Torrance, California, United States
PIH Health Hematology Medical Oncology
Whittier, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
UCHealth Memorial Hospital
Colorado Springs, Colorado, United States
UCHealth Harmony
Fort Collins, Colorado, United States
Colorado West Healthcare System - Grand Valley Oncology
Grand Junction, Colorado, United States
USO-Rocky Mountain Cancer Center
Littleton, Colorado, United States
Florida Cancer Specialists - South
Fort Myers, Florida, United States
Memorial Regional Hospital
Hollywood, Florida, United States
Millennium Oncology Research Clinic
Hollywood, Florida, United States
University of Miami Hospital and Clinics, Sylvester Cancer Center
Miami, Florida, United States
Florida Cancer Specialist- East
West Palm Beach, Florida, United States
Dwight D Eisenhower Army Medical Center
Fort Gordon, Georgia, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
Central Georgia Cancer Care
Macon, Georgia, United States
Summit Cancer Care DBA Candler Medical Oncology Practice
Savannah, Georgia, United States
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
The University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky, United States
Sarah Cannon Research Institute
Baton Rouge, Louisiana, United States
Chesapeake Urology
Towson, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Reliant Medical Group
Worcester, Massachusetts, United States
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
Minnesota Oncology/Hematology PA
Minneapolis, Minnesota, United States
Care Access - Clifton
Clifton, New Jersey, United States
Maimonides Cancer Center
Brooklyn, New York, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Mineola, New York, United States
Laura and Isaac Perlmutter Cancer Center
New York, New York, United States
Associated Medical Professionals - Urology
Syracuse, New York, United States
Clinical Research Alliance
Westbury, New York, United States
TriState Urologic Services PSC Inc.
Cincinnati, Ohio, United States
Northwest Cancer Specialist
Tigard, Oregon, United States
MidLantic urology
Bala-Cynwyd, Pennsylvania, United States
AHN Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Tennessee Oncology Chattanooga-SCRI
Chattanooga, Tennessee, United States
University of Tennessee Medical Center
Knoxville, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Texas Oncology - Balcones
Austin, Texas, United States
Parkland Health and Hospital System
Dallas, Texas, United States
UT Southwestern Medical Center
Dallas, Texas, United States
Texas Oncology - Carrollton
Flower Mound, Texas, United States
The Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
Urology San Antonio Research
San Antonio, Texas, United States
USO - Texas Oncology Gulf Coast
Sugar Land, Texas, United States
Baylor Scott & White Medical Center - Temple
Temple, Texas, United States
US Oncology Research Network
The Woodlands, Texas, United States
Texas Oncology - Longview Cancer Center
Tyler, Texas, United States
Huntsman Cancer Institute
Salt Lake City, Utah, United States
The University of Vermont Medical Center Inc.
Burlington, Vermont, United States
Oncology and Hematology Associates of Southwest Virginia Inc
Roanoke, Virginia, United States
Instituto de Investigaciones Clínicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Investigaciones Clinicas Moleculares (ICM)
Buenos Aires, Buenos Aires F.D., Argentina
Asociación de Beneficencia Hospital Sirio Libanés
Buenos Aires, Buenos Air, Argentina
Centro de Investigaciones Metabólicas (CINME)
Ciudad Autónoma de Buenos Aire, Buenos Air, Argentina
Fundación Cenit Para La Investigación En Neurociencias
CABA, Ciudad Autónoma de Buenos Aire, Argentina
Centro Medico Privado CEMAIC
Capital, Córdoba Province, Argentina
Instituto Médico Río Cuarto
Río Cuarto, Córdoba Province, Argentina
Clinica Viedma
Viedma, Río Negro Province, Argentina
Centro Medico San Roque
San Miguel de Tucumán, Tucumán Province, Argentina
Centro Oncologico Korben
Buenos Aires, , Argentina
Fundación Respirar
Buenos Aires, , Argentina
Centro Urológico Profesor Bengió
Córdoba, , Argentina
Centro Polivalente de Asistencia e Investigacion Clinica - CER San Juan
San Juan, , Argentina
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
Coffs Harbour Health Campus
Coffs Harbour, New South Wales, Australia
St Vincent's Hospital
Darlinghurst, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Macquarie University
Macquarie University, New South Wales, Australia
Icon Cancer Centre South Brisbane
South Brisbane, Queensland, Australia
Tasman Oncology Research
Southport, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia
Ashford Cancer Centre Research
Kurralta Park, South Australia, Australia
Icon Cancer Centre Hobart
Hobart, Tasmania, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
Monash Health
Clayton, Victoria, Australia
Barwon Health
Geelong, Victoria, Australia
Austin Health
Heidelberg, Victoria, Australia
St Vincent's Hospital
Melbourne, Victoria, Australia
Epworth Freemasons
Richmond, Victoria, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Onze Lieve Vrouw Ziekenhuis Aalst
Aalst, Oost-Vlaanderen, Belgium
UZ Gent
Ghent, Oost-Vlaanderen, Belgium
AZ Groeninge Campus Kennedylaan
Kortrijk, West-Vlaanderen, Belgium
CHU UCL Namur/Site Sainte Elisabeth
Namur, , Belgium
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará
Fortaleza, Ceará, Brazil
Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, Brazil
Centro Avançado de Tratamento Oncológico- CENANTRON
Belo Horizonte, Minas Gerais, Brazil
Centro Integrado de Oncologia de Curitiba
Curitiba, Paraná, Brazil
Hospital de Cancer de Londrina
Londrina, Paraná, Brazil
Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Oncologia Saint Gallen
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Clínica de Oncologia Reichow
Blumenau, Santa Catarina, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil
Instituto de de Educação, pesquisa e Gestão em Saúde
Rio de Janeiro, , Brazil
Instituto do Cancer Arnaldo Vieira de Carvalho
São Paulo, , Brazil
Icesp - Instituto Do Câncer Do Estado de São Paulo
São Paulo, , Brazil
Núcleo de Pesquisa Clínica da Rede São Camilo
São Paulo, , Brazil
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Afflilated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Second Affiliated hospital of Anhui Medical University
Hefei, Anhui, China
Wannan Medical College Yijishan Hospital
Wuhu, Anhui, China
Beijing Hospital
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Beijing Cancer hospital
Beijing, Beijing Municipality, China
Sun Yat-Sen University Cancer Centre
Guangzhou, Guangdong, China
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, China
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Wuhan Union Hospital
Wuhan, Hubei, China
Tongji Hospital Tongji Medical,Science & Technology
Wuhan, Hubei, China
Hunan Provincial People's Hospital
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
Hunan Cancer Hospital
Changsha, Hunan, China
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Jilin Cancer Hospital
Changchun, Jilin, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Huadong Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Nanchong Central Hospital
Nanchong, Sichuan, China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
The Second Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital, Zhejiang University
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Ningbo First Hospital
Ningbo, Zhejiang, China
Nemocnice Horovice
Hořovice, Beroun, Czechia
Masarykuv onkologicky ustav
Brno, Brno-město, Czechia
Fakultni nemocnice Kralovske Vinohrady
Prague, Praha 10, Czechia
Fakultni Thomayerova nemocnice
Prague, Praha 4, Czechia
Oblastni nemocnice Pribram
Příbram, Příbram, Czechia
Fakultni Nemocnice u sv. Anny v Brne
Brno, South Moravian, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, , Czechia
Urocentrum Praha
Prague, , Czechia
Centre Leon Berard
Lyon, Auvergne-Rhône-Alpes, France
Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan
Brest, Brittany Region, France
Polyclinique De Blois
La Chaussée-Saint-Victor, Centre-Val de Loire, France
Centre Georges François Leclerc
Dijon, Côte-d'Or, France
CHU Besançon
Besançon, Doubs, France
Centre de Cancérologie du Grand Montpellier
Montpellier, Languedoc-Roussillon, France
Hôpital privé du Confluent SAS
Nantes, Loire-Atlantique, France
Institut de Cancérologie de l'Ouest
Saint-Herblain, Loire-Atlantique, France
Institut Paoli-Calmettes
Marseille, Provence-Alpes-Côte d'Azur Region, France
Clinique Victor Hugo Le Mans
Le Mans, Sarthe, France
Hôpital Européen Georges Pompidou
Paris, , France
Universitaetsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
NCT
Heidelberg, Baden-Wurttemberg, Germany
Studienpraxis Urologie
Nürtingen, Baden-Wurttemberg, Germany
Universitaetsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Universitaetsklinikum Tuebingen
Tübingen, Baden-Würt, Germany
Klinikum Rechts Der Isar Der Technischen Universität München
Munich, Bavaria, Germany
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany
Urologicum Duisburg Fachärztesozietät - Walsum
Duisburg, North Rhine-Westphalia, Germany
Urologische Gemeinschaftspraxis Heinsberg
Heinsberg, North Rhine-Westphalia, Germany
Universitätsklinikum Münster - Albert Schweitzer Campus
Münster, North Rhine-Westphalia, Germany
Urologische Gemeinschaftspraxis Wesel
Wesel, North Rhine-Westphalia, Germany
InVO Institut für Versorgungsforschung in der Onkologie
Koblenz, Rhineland-Palatinate, Germany
Universitätsmedizin Johannes Gutenberg Universität Mainz
Mainz, Rhineland-Palatinate, Germany
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Urologie Neandertal - Praxis Mettmann
Mettmann, , Germany
Klinikum Nürnberg Nord
Nuremberg, , Germany
University Hospital of Patras
Pátrai, Achaḯa, Greece
Agios Savvas Regional Cancer Hospital
Athens, Attikí, Greece
Alexandra Hospital
Athens, Attikí, Greece
Attikon General University Hospital
Chaïdári, Attikí, Greece
University General Hospital of Heraklion
Heraklion, Irakleío, Greece
Bacs-Kiskun Megyei Korhaz
Kecskemét, Bács-Kiskun county, Hungary
Petz Aladar Egyetemi Oktato Korhaz
Győr, Győr-Moson-Sopron, Hungary
Országos Onkológiai Intézet
Budapest, Pest County, Hungary
Magyar Honvedseg Egeszsegugyi Kozpont
Budapest, , Hungary
Meir Medical Center
Kfar Saba, Central District, Israel
Rabin Medical Center
Petah Tikva, Central District, Israel
Sheba Medical Center
Ramat Gan, Central District, Israel
Yitzhak Shamir Medical Center
Ẕerifin, Central District, Israel
Hadassah Medical Center
Jerusalem, Jerusalem, Israel
Rambam Health Care Campus
Haifa, Northern District, Israel
Sourasky Medical Center
Tel Aviv, Tell Abīb, Israel
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola, Emilia-Romagna, Italy
Fondazione Policlinico Universitario Agostino Gemelli
Rome, Lazio, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
Istituto Oncologico Veneto IRCCS
Castelfranco Veneto, Veneto, Italy
Istituto Europeo di Oncologia IRCCS
Milan, , Italy
Azienda Ospedaliera Santa Maria Terni
Terni, , Italy
APSS- Presidio Ospedaliero S. Chiara
Trento, , Italy
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East
Kashiwa, Chiba, Japan
Kimitsu Chuo Hospital
Kisarazu, Chiba, Japan
Toho University Sakura Medical Center
Sakura, Chiba, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, Japan
Kagawa University Hospital
Kita, Kagawa-ken, Japan
Yokohama City University Medical Center
Yokohama, Kanagawa, Japan
Nagano Municipal Hospital
Tomitake, Nagano, Japan
Hamamatsu University Hospital
Hamamatsu, Shizuoka, Japan
Showa University Hospital
Shinagawa, Tokyo, Japan
National Hospital Organization Kumamoto Medical Center
Kumamoto, , Japan
Osaka International Cancer Institute
Osaka, , Japan
Osaka Metropolitan University Hospital
Osaka, , Japan
Actualidad Basada en la Investigación del Cáncer
Guadalajara, Jalisco, Mexico
Health Pharma Professional Research S.A. de C.V:
Mexico City, Mexico City, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Centro Para El Desarrollo de La Medicina Y de Asistencia Medica Especializada S.C.
Culiacán, Sinaloa, Mexico
Scientia Investigacion Clinica S.C.
Chihuahua City, , Mexico
Centro de Investigacion Clinica de Oaxaca
Oaxaca City, , Mexico
ETZ Elisabeth
Tilburg, North Brabant, Netherlands
University Medical Center Groningen
Groningen, , Netherlands
Clinical Best Solutions
Lublin, Lublin Voivodeship, Poland
Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego
Opole, Opole Voivodeship, Poland
Szpitale Pomorskie Sp. z o. o.
Gdynia, Pomeranian Voivodeship, Poland
Salve Medica
Lodz, Łódź Voivodeship, Poland
Provita Profamilia
Piotrkow Trybunalski, Łódź Voivodeship, Poland
C.M.D.T.A. Neomed
Brasov, Brașov County, Romania
Amethyst Radiotherapy Center
Florești, Cluj, Romania
Ovidius Clinical Hospital OCH
Ovidiu, Constanța County, Romania
Centrul de Oncologie "Sfântul Nectarie"
Craiova, Dolj, Romania
Radiology Therapeutic Center
Otopeni, Ilfov, Romania
Oncopremium Team
Baia Mare, Maramureş, Romania
SC Memorial Healthcare International SRL
Bucharest, , Romania
Gral Medical Diagnostic Center
Bucharest, , Romania
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Severance Hospital, Yonsei University Health System
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Asan Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Instituto Catalan de Oncologia - Hospital Duran i Reynals
Hospitalet, Barcelona [Barcelona], Spain
Hospital General Universitario Gregorio Marañon
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario 12 de Octubre
Madrid, Madrid, Comunidad de, Spain
Fundación Instituto Valenciano de Oncología
Valencia, Valenciana, Comunitat, Spain
Hospital Infanta Cristina
Badajoz, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
National Taiwan University Hospital
Taipei City, Taipei, Taiwan
Taipei Veterans General Hospital
Taipei City, Taipei, Taiwan
China Medical University Hospital
Taichung, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
National Cheng Kung University Hospital
Tainan City, , Taiwan
Chang Gung Medical Foundation-Linkou Branch
Taoyuan District, , Taiwan
Medipol Mega Universite Hastanesi
Stanbul, Istanbul, Turkey (Türkiye)
Izmir Medical Park Hospital
Izmir, Karsiyaka, İzmir, Turkey (Türkiye)
Baskent University Dr. Turgut Noyan Research and Training Center
Adana, , Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi
Ankara, , Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Hastanesi
Ankara, , Turkey (Türkiye)
Dicle Üniversitesi
Diyarbakır, , Turkey (Türkiye)
Trakya University
Edirne, , Turkey (Türkiye)
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi
Istanbul, , Turkey (Türkiye)
İnönü Üniversitesi Turgut Özal Tıp Merkezi
Malatya, , Turkey (Türkiye)
Royal Blackburn Hospital
Blackburn, Blackburn With Darwen, United Kingdom
Colchester General Hospital
Colchester, Essex, United Kingdom
University College London Hospital
London, London, City of, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I3Y-MC-JPEG
Identifier Type: OTHER
Identifier Source: secondary_id
2022-500461-28-06
Identifier Type: OTHER
Identifier Source: secondary_id
18448
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.